Filing Flows

Filing Flows › Escalon Medical (ESMC) › Q3 FY25

Escalon Medical (ESMC) Q3 FY25 earnings results (third quarter fiscal 2025)

10-Q filed May 14, 2025

Escalon Medical (ESMC) reported revenue of $3.5M for the third quarter fiscal 2025 (Q3 FY25), +29% from a year earlier and +8% from the quarter before. Operating margin was 7.9%, net earnings $271K (7.8% of revenue).

Revenue$3.5M
Year over year+29%
Quarter over quarter+8%
Operating margin7.9%
Net earnings$271K

Escalon Medical, Q3 FY25: revenue $3.5M (+29% year over year), operating margin 7.9%, net earnings $271K, operating cash flow $31K. The chart follows the revenue to costs, profit and cash.

Q3 FY25AmountQ/QY/Y
Revenue$3.5M+8%+29%
Operating profit$276K+8%—
Net earnings$271K+10%—
Operating cash flow$31K-90%-82%

What changed

Revenue was $3.5M in Q3 FY25, up 29% year over year and up 8% from the previous quarter. Product was the largest line at 95% of revenue. Product added $747K year over year (up 29%), 96% of the total change.

Operating profit was $276K, a 7.9% margin (up 13.8 points year over year). Total costs grew 12% against revenue growth of 29%. The fastest-growing cost line was Cost of revenue (+19%). Net earnings were $271K. The effective tax rate was 0.0%.

Operating cash flow was $31K (down 82% year over year), 11% of net earnings. Non-cash charges added back $9K of depreciation and amortization. Working capital and other items used $250K.

Questions

What was Escalon Medical's revenue in the third quarter fiscal 2025?

Escalon Medical (ESMC) reported revenue of $3.5M for the third quarter fiscal 2025 (Q3 FY25), +29% from a year earlier and +8% from the quarter before.

Was Escalon Medical profitable in the third quarter fiscal 2025?

Operating profit was $276K (7.9% of revenue) and net earnings $271K.

Open the interactive Sankey →

Source: Escalon Medical 10-Q on SEC EDGAR.